Roberts, Glore & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.38M | Sell |
9,931
-813
| -8% | -$114K | 0.38% | 63 |
|
|
2025
Q4 | $1.32M | Sell |
10,744
-740
| -6% | -$89.9K | 0.35% | 67 |
|
|
2025
Q3 | $1.27M | Sell |
11,484
-380
| -3% | -$43.2K | 0.35% | 70 |
|
|
2025
Q2 | $1.32M | Sell |
11,864
-270
| -2% | -$28.7K | 0.38% | 64 |
|
|
2025
Q1 | $1.36M | Sell |
12,134
-1,402
| -10% | -$145K | 0.41% | 62 |
|
|
2024
Q4 | $1.25M | Sell |
13,536
-1,604
| -11% | -$144K | 0.37% | 66 |
|
|
2024
Q3 | $1.27M | Sell |
15,140
-165
| -1% | -$12.6K | 0.37% | 70 |
|
|
2024
Q2 | $1.05M | Buy |
15,305
+300
| +2% | +$20K | 0.32% | 78 |
|
|
2024
Q1 | $1.1M | Sell |
15,005
-3,320
| -18% | -$255K | 0.33% | 79 |
|
|
2023
Q4 | $1.48M | Sell |
18,325
-1,285
| -7% | -$100K | 0.46% | 60 |
|
|
2023
Q3 | $1.47M | Sell |
19,610
-1,471
| -7% | -$113K | 0.49% | 54 |
|
|
2023
Q2 | $1.62M | Sell |
21,081
-50
| -0.2% | -$3.99K | 0.52% | 51 |
|
|
2023
Q1 | $1.75M | Sell |
21,131
-498
| -2% | -$41.2K | 0.59% | 44 |
|
|
2022
Q4 | $1.86M | Sell |
21,629
-7,982
| -27% | -$632K | 0.64% | 44 |
|
|
2022
Q3 | $1.83M | Sell |
29,611
-5,449
| -16% | -$344K | 0.65% | 43 |
|
|
2022
Q2 | $2.17M | Sell |
35,060
-375
| -1% | -$23.2K | 0.72% | 40 |
|
|
2022
Q1 | $2.11M | Sell |
35,435
-605
| -2% | -$38.7K | 0.61% | 47 |
|
|
2021
Q4 | $2.62M | Sell |
36,040
-720
| -2% | -$49.6K | 0.69% | 37 |
|
|
2021
Q3 | $2.57M | Sell |
36,760
-342
| -0.9% | -$24K | 0.78% | 35 |
|
|
2021
Q2 | $2.56M | Sell |
37,102
-465
| -1% | -$31.1K | 0.76% | 34 |
|
|
2021
Q1 | $2.43M | Sell |
37,567
-557
| -1% | -$35.9K | 0.76% | 37 |
|
|
2020
Q4 | $2.22M | Buy |
38,124
+1,370
| +4% | +$82.7K | 0.73% | 37 |
|
|
2020
Q3 | $2.32M | Buy |
36,754
+40
| +0.1% | +$2.77K | 0.83% | 33 |
|
|
2020
Q2 | $2.82M | Sell |
36,714
-1,470
| -4% | -$113K | 1.11% | 24 |
|
|
2020
Q1 | $2.85M | Buy |
38,184
+570
| +2% | +$39.4K | 1.22% | 21 |
|
|
2019
Q4 | $2.44M | Buy |
37,614
+12,264
| +48% | +$799K | 0.93% | 29 |
|
|
2019
Q3 | $1.61M | Sell |
25,350
-470
| -2% | -$30.7K | 0.98% | 31 |
|
|
2019
Q2 | $1.74M | Hold |
25,820
| – | – | 1.06% | 28 |
|
|
2019
Q1 | $1.68M | Sell |
25,820
-650
| -2% | -$43.2K | 1.05% | 29 |
|
|
2018
Q4 | $1.66M | Sell |
26,470
-390
| -1% | -$27.3K | 1.17% | 24 |
|
|
2018
Q3 | $2.07M | Sell |
26,860
-50
| -0.2% | -$3.78K | 1.19% | 22 |
|
|
2018
Q2 | $1.91M | Buy |
26,910
+50
| +0.2% | +$3.53K | 1.16% | 22 |
|
|
2018
Q1 | $2.02M | Sell |
26,860
-50
| -0.2% | -$3.98K | 1.25% | 22 |
|
|
2017
Q4 | $1.93M | Buy |
26,910
+160
| +0.6% | +$12.2K | 1.18% | 23 |
|
|
2017
Q3 | $2.17M | Buy |
26,750
+895
| +3% | +$68.4K | 1.4% | 20 |
|
|
2017
Q2 | $1.83M | Buy |
25,855
+1,280
| +5% | +$85.2K | 1.22% | 22 |
|
|
2017
Q1 | $1.67M | Sell |
24,575
-417
| -2% | -$29.3K | 1.15% | 26 |
|
|
2016
Q4 | $1.79M | Buy |
24,992
+870
| +4% | +$64.7K | 1.25% | 19 |
|
|
2016
Q3 | $1.91M | Buy |
24,122
+93
| +0.4% | +$7.55K | 1.37% | 18 |
|
|
2016
Q2 | $2M | Sell |
24,029
-214
| -0.9% | -$19K | 1.52% | 15 |
|
|
2016
Q1 | $2.23M | Sell |
24,243
-345
| -1% | -$31.1K | 1.69% | 11 |
|
|
2015
Q4 | $2.49M | Sell |
24,588
-340
| -1% | -$35.4K | 1.88% | 11 |
|
|
2015
Q3 | $2.45M | Sell |
24,928
-2,127
| -8% | -$236K | 1.91% | 13 |
|
|
2015
Q2 | $3.17M | Sell |
27,055
-1,025
| -4% | -$112K | 2.22% | 10 |
|
|
2015
Q1 | $2.75M | Sell |
28,080
-494
| -2% | -$50.2K | 1.9% | 12 |
|
|
2014
Q4 | $2.69M | Sell |
28,574
-430
| -1% | -$44.5K | 1.8% | 13 |
|
|
2014
Q3 | $3.09M | Sell |
29,004
-2,206
| -7% | -$216K | 2.14% | 10 |
|
|
2014
Q2 | $2.59M | Sell |
31,210
-1,880
| -6% | -$146K | 1.75% | 13 |
|
|
2014
Q1 | $2.35M | Sell |
33,090
-5,875
| -15% | -$461K | 1.62% | 14 |
|
|
2013
Q4 | $2.93M | Sell |
38,965
-1,696
| -4% | -$118K | 2.03% | 7 |
|
|
2013
Q3 | $2.56M | Sell |
40,661
-13,093
| -24% | -$783K | 1.89% | 11 |
|
|
2013
Q2 | $2.76M | Buy |
+53,754
| New | +$2.8M | 1.7% | 12 |
|
Other funds holding GILD
VCM
VPM
Roberts, Glore & Co's GILD Position: Q1 2026 in Review
Roberts, Glore & Co reduced its Gilead Sciences (GILD) stake by 7.6% in Q1 2026, selling an estimated $114K and leaving 9,931 shares worth $1.38M. The position accounts for 0.38% of the portfolio, ranked #63.
Roberts, Glore & Co first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.17M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Roberts, Glore & Co held 9,931 shares of Gilead Sciences worth $1.38M as of Q1 2026.
- Roberts, Glore & Co sold 813 Gilead Sciences shares in Q1 2026, an estimated $114K.
- Gilead Sciences made up 0.38% of Roberts, Glore & Co's portfolio in Q1 2026, its #63 holding.
- Roberts, Glore & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Roberts, Glore & Co's Gilead Sciences position peaked at $3.17M in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.